Literature DB >> 27229705

Rate of intraoperative complications during cataract surgery following intravitreal injections.

P Hahn1,2, K Jiramongkolchai2, S Stinnett2, M Daluvoy2, T Kim2.   

Abstract

PurposeTo investigate the effect of prior intravitreal injections on intraoperative and postoperative complication rates associated with cataract surgery.MethodsA retrospective cohort analysis reviewed 10 105 cataract surgery procedures performed by experienced surgeons at the Duke Eye Center from 1 January 2005 to 10 December 2012. A group of 197 eyes with prior intravitreal injections was compared with an equal number of matched control eyes without prior injection using the Fisher's exact test of difference in proportions and the Wilcoxon rank-sum test of difference in means. Outcomes analyzed included baseline demographic information, preoperative clinical characteristics, prevalence of intraoperative complications, and postoperative intraocular pressure, glaucoma surgery, and glaucoma medication requirement through 1 year following cataract surgery.ResultsAn increased rate of intraoperative complications was identified during cataract surgery in eyes with prior intravitreal injections compared with control eyes (3 vs 0%, P=0.030). Injection eyes required more glaucoma medications at 1 year, but no difference was identified if steroid injections were excluded. No difference in postoperative IOP or glaucoma surgery was identified. No cases of endophthalmitis were reported.ConclusionsA history of intravitreal injections may be a risk factor for cataract surgery-related intraoperative complications. We hypothesize this may be due to unidentified iatrogenic lens trauma during intravitreal injections. Particular attention to the posterior capsule during preoperative assessment and intraoperatively is recommended in eyes undergoing cataract surgery with a prior history of intravitreal injections.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27229705      PMCID: PMC4985667          DOI: 10.1038/eye.2016.109

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


  22 in total

1.  Effect of Prior Anti-VEGF Injections on the Risk of Retained Lens Fragments and Endophthalmitis after Cataract Surgery in the Elderly.

Authors:  Paul Hahn; Arseniy P Yashkin; Frank A Sloan
Journal:  Ophthalmology       Date:  2015-08-13       Impact factor: 12.079

2.  Ophthalmic antibiotics and antimicrobial resistance a randomized, controlled study of patients undergoing intravitreal injections.

Authors:  Stephen J Kim; Hassanain S Toma
Journal:  Ophthalmology       Date:  2011-03-21       Impact factor: 12.079

3.  Effect on intraocular pressure in patients receiving unilateral intravitreal anti-vascular endothelial growth factor injections.

Authors:  Quan V Hoang; Luis S Mendonca; Kara E Della Torre; Jesse J Jung; Angela J Tsuang; K Bailey Freund
Journal:  Ophthalmology       Date:  2011-11-04       Impact factor: 12.079

4.  Ocular complications after anti-vascular endothelial growth factor therapy in Medicare patients with age-related macular degeneration.

Authors:  Shelley Day; Kofi Acquah; Prithvi Mruthyunjaya; Daniel S Grossman; Paul P Lee; Frank A Sloan
Journal:  Am J Ophthalmol       Date:  2011-06-12       Impact factor: 5.258

5.  Intraocular pressure in eyes receiving monthly ranibizumab in 2 pivotal age-related macular degeneration clinical trials.

Authors:  Sophie J Bakri; Darius M Moshfeghi; Steve Francom; Amy Chen Rundle; Daniel S Reshef; Paul P Lee; Carol Schaeffer; Roman G Rubio; Phillip Lai
Journal:  Ophthalmology       Date:  2014-01-06       Impact factor: 12.079

6.  Pegaptanib for neovascular age-related macular degeneration.

Authors:  Evangelos S Gragoudas; Anthony P Adamis; Emmett T Cunningham; Matthew Feinsod; David R Guyer
Journal:  N Engl J Med       Date:  2004-12-30       Impact factor: 91.245

7.  Diffusion of technologies for the care of older adults with exudative age-related macular degeneration.

Authors:  Joshua D Stein; Brian W Hanrahan; Grant M Comer; Frank A Sloan
Journal:  Am J Ophthalmol       Date:  2012-12-06       Impact factor: 5.258

8.  Accidental injections of dexamethasone intravitreal implant (Ozurdex) into the crystalline lens.

Authors:  Javier Coca-Robinot; Bruno Casco-Silva; Felix Armadá-Maresca; Jesús García-Martínez
Journal:  Eur J Ophthalmol       Date:  2014-02-25       Impact factor: 2.597

9.  Cataract surgery after intravitreal injection of triamcinolone acetonide.

Authors:  J B Jonas; I Kreissig; R F Degenring
Journal:  Eye (Lond)       Date:  2004-04       Impact factor: 3.775

10.  Ranibizumab versus verteporfin photodynamic therapy for neovascular age-related macular degeneration: Two-year results of the ANCHOR study.

Authors:  David M Brown; Mark Michels; Peter K Kaiser; Jeffrey S Heier; Judy P Sy; Tsontcho Ianchulev
Journal:  Ophthalmology       Date:  2009-01       Impact factor: 12.079

View more
  5 in total

1.  Association of Cataract Surgical Outcomes With Late Surgeon Career Stages: A Population-Based Cohort Study.

Authors:  Robert J Campbell; Sherif R El-Defrawy; Sudeep S Gill; Marlo Whitehead; Erica de L P Campbell; Philip L Hooper; Chaim M Bell; Martin W Ten Hove
Journal:  JAMA Ophthalmol       Date:  2019-01-01       Impact factor: 7.389

2.  The Royal College of Ophthalmologists Commissioning guidelines on age macular degeneration: executive summary.

Authors:  Shruti Chandra; Martin McKibbin; Sajjad Mahmood; Louise Downey; Beth Barnes; Sobha Sivaprasad
Journal:  Eye (Lond)       Date:  2022-05-27       Impact factor: 4.456

3.  Redox-Responsive Hyaluronic Acid-Based Nanogels for the Topical Delivery of the Visual Chromophore to Retinal Photoreceptors.

Authors:  Amine M Laradji; Alexander V Kolesnikov; Bedia B Karakoçak; Vladimir J Kefalov; Nathan Ravi
Journal:  ACS Omega       Date:  2021-02-22

4.  Risk of Posterior Capsular Rupture during Phacoemulsification in Patients with the History of Anti-VEGF Intravitreal Injections: Results from the Pan-American Collaborative Retina Study (PACORES) Group.

Authors:  Raul Velez-Montoya; Idaira Sanchez-Santos; Mauricio Galvan-Chavez; Lihteh Wu; J Fernando Arevalo; María H Berrocal; Arturo A Alezzandrini; Marta S Figueroa; Roberto Gallego-Pinazo; Rosa Dolz-Marco; Clara Martinez-Rubio; Roberto Gonzalez-Salinas
Journal:  J Ophthalmol       Date:  2021-10-11       Impact factor: 1.909

5.  Effective splicing restoration of a deep-intronic ABCA4 variant in cone photoreceptor precursor cells by CRISPR/SpCas9 approaches.

Authors:  Pietro De Angeli; Peggy Reuter; Stefan Hauser; Ludger Schöls; Katarina Stingl; Bernd Wissinger; Susanne Kohl
Journal:  Mol Ther Nucleic Acids       Date:  2022-07-31       Impact factor: 10.183

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.